Seeger K, Taube T, Eckert C, Hanel C, Pogodda M, Henze G
Charité, Otto-Heubner-Centre for Paediatric and Adolescent Medicine, Department of Paediatric Oncology/Haematology, Humboldt-University, Berlin, Germany.
Br J Haematol. 2001 May;113(2):318-22. doi: 10.1046/j.1365-2141.2001.02732.x.
Rearrangements of the T-cell receptor (TCR) and immunoglobulin genes are considered as useful clonal markers in lymphoproliferative disorders of B- and T-cell lineage, and are frequently used for the detection of minimal residual disease (MRD). In this paper, we report on the unexpected results of an extensive analysis of TCR-delta chain gene rearrangement frequencies and patterns in leukaemic bone marrow DNA samples collected from 438 children with initial (n = 112) or relapsed (n = 326) acute lymphoblastic leukaemia (ALL). By applying a previously described multiplex polymerase chain reaction, the overall incidence of non-deleted TCR-delta gene rearrangements in ALL was 47% (206/438), 52% in initial ALL (58/112) and 45% in relapsed ALL (148/326). As expected, the majority of B-cell precursor (BCP) ALL had incomplete Vdelta2-Ddelta3 or Ddelta2-Ddelta3 TCR-delta gene rearrangements, whereas most T-ALL showed complete rearrangements of the TCR-delta gene locus (Vdelta1-Jdelta1, Vdelta2-Jdelta1, Vdelta3-Jdelta1). However, unexpectedly, 5/206 rearranged TCR-delta alleles in BCP-ALL showed a complete Vdelta-(Ddelta)-Jdelta gene rearrangement pattern, and 3/31 T-ALL had an incomplete recombination. Theoretically, complete TCR-delta gene rearrangements should not occur in cells other than T-lymphocytes and have only been reported once previously in BCP-ALL. The data contribute to the discussion about the reliable screening for clonal markers in ALL.
T细胞受体(TCR)和免疫球蛋白基因重排被认为是B细胞和T细胞系淋巴增殖性疾病中有用的克隆标志物,并经常用于检测微小残留病(MRD)。在本文中,我们报告了对438例初发(n = 112)或复发(n = 326)急性淋巴细胞白血病(ALL)儿童的白血病骨髓DNA样本中TCR-δ链基因重排频率和模式进行广泛分析时得到的意外结果。通过应用先前描述的多重聚合酶链反应,ALL中非缺失TCR-δ基因重排的总体发生率为47%(206/438),初发ALL中为52%(58/112),复发ALL中为45%(148/326)。正如预期的那样,大多数B细胞前体(BCP)ALL具有不完全的Vδ2-Dδ3或Dδ2-Dδ3 TCR-δ基因重排,而大多数T-ALL显示TCR-δ基因座的完全重排(Vδ1-Jδ1、Vδ2-Jδ1、Vδ3-Jδ1)。然而,出乎意料的是,BCP-ALL中5/206重排的TCR-δ等位基因显示出完全的Vδ-(Dδ)-Jδ基因重排模式,3/31 T-ALL具有不完全重排。理论上,完全的TCR-δ基因重排不应发生在T淋巴细胞以外的细胞中,并且此前仅在BCP-ALL中报道过一次。这些数据有助于关于ALL中克隆标志物可靠筛选的讨论。